PRESS RELEASE Nanterre, July 17, 2025 VINCI Airports – Traffic as of June 30, 2025 6.7% increase in traffic in Q2 2025 compared to 2024; increase in seat supply and demand still strong in most regionsDouble-digit traffic growth in Japan, Mexico, Budapest, Cabo Verde and Cambodia.Very good traffic trend also recorded in Portugal, Edinburgh and Belgrade In the paragraphs below, and unless otherwise stated, the variations refer to traffic levels for the 2nd quarter of 2025 compared to the 2nd quarter of 2024. ...

Core Viewpoint - Liberty Defense Holdings Ltd. is increasing its non-brokered equity financing to raise a maximum of C$4.4 million by offering 20 million units at C$0.22 per unit [1][3]. Financing Details - Each unit consists of one common share and one warrant, with the warrant allowing the purchase of one common share at an exercise price of C$0.35 [2]. - The offering is conducted under the Listed Issuer Financing Exemption, allowing for immediate resale of the units without a hold period [3]. - The company may pay a finder's fee of up to 6.0% of the gross proceeds and issue non-transferable warrants equal to 6.0% of the units issued [4]. Use of Proceeds - Proceeds from the offering will be allocated for purchasing inventory for HEXWAVE technology production, investor relations, marketing initiatives, operating expenses, and general working capital [5]. Closing Timeline - The offering is scheduled to close on or about July 22, 2025, subject to receiving a minimum of C$2,500,000 in subscriptions and necessary approvals [6]. Company Overview - Liberty provides advanced security solutions for concealed weapons detection in high-traffic areas, with products like HEXWAVE and other imaging technologies licensed from MIT [8][9].

Core Insights - Chibougamau Independent Mines Inc. is highlighting updates from Cerrado Gold Inc. regarding the Mont Sorcier Iron/vanadium project, which is located near Chibougamau, Quebec [1][4] Project Update - The Mont Sorcier project is undergoing detailed metallurgical test work and flow sheet design, with an infill drill program initiated to update resources to Proven and Probable categories for ongoing feasibility [2] - Assay results from the drilling program are still pending [2] Feasibility Study - A Bankable Feasibility Study is being conducted to provide detailed insights into the project's potential, building on the previous 2022 NI 43-101 Preliminary Economic Assessment (PEA) that indicated a project NPV at 8% of US$1.6 billion based on iron concentrates with 65% iron content [3] - Improved metallurgical results suggest the potential to produce a high purity DRI grade iron ore concentrate exceeding 67% iron, which could enhance project value and support the Green Steel transition [3] Royalty Information - Chibougamau Independent Mines holds a 2% Gross Metal Royalty on iron and vanadium production from the Mont Sorcier property [4]

SOGECLAIRBusiness corporation with a capital of 3 204 901 EurosHead Office: 7 avenue Albert Durand – 31700 BLAGNAC (France)Tel.: +33 (0)5.61.71.71.71 – www.sogeclair.com335 218 269 R.C.S. TOULOUSE Information concerning the total number of voting rights and shares in the share capitalSection L.233-8 II of French commercial law (“Code de commerce”) and section 223-16 of the general rules of the French Financial Markets Authority (“Règlement général de l’Autorité des Marchés Financiers”) DATETotal number o ...

Syensqo Appoints Two New Board Members Brussels, Belgium – July 17, 2025 - 17:30 CEST New Directors Bring Industry, Innovation and Leadership Experience to Advance Syensqo’s Evolution to a Specialty Chemicals Company SYENSQO SA (“Syensqo” or “the Company”) is pleased to announce the appointment of Dr. Cynthia Arnold and Augusto Di Donfrancesco as new members of its Board of Directors, effective July 17, 2025. They replace Matti Lievonen and Nadine Leslie who are stepping down from the Board to pursue other ...

Siili Solutions Plc Announcement 17.7.2025 Siili Solutions Plc: Share Repurchase 17.7.2025 In the Helsinki Stock Exchange Trade date 17.7.2025 Bourse trade Buy Share SIILI Amount 720SharesAverage price/ share 6,7000EURTotal cost 4 824,00EUR Siili Solutions Plc now holds a total of 31 698 shares<td colspan="2" st ...

FINANCIAL PRESS RELEASE FIRST-HALF 2025 TURNOVER* *under audit Strong performance in a mixed market environment Consolidated revenue stable at €108.3 million (+0.2%)+4.7% growth for Champagne Pommery, reflecting the success of the premiumization strategy Reims, July 17, 2025In the first half of 2025, Vranken-Pommery Monopole once again demonstrated its resilience with stable revenue (+0.2% vs. 2024) in a still volatile economic environment: Significant trade tensions, particularly between Europe and the Un ...

Core Insights - Oncotelic Therapeutics is advancing the evaluation of OT-101, an investigational antisense oligonucleotide targeting TGFB2, as a potential treatment for pancreatic ductal adenocarcinoma (PDAC) [1][5] - New research indicates that TGFB2 expression and methylation may serve as prognostic markers for overall survival in PDAC patients, particularly in younger cohorts [1][2][3] Company Overview - Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing RNA-targeted and small-molecule therapeutics for cancer and rare diseases [1][6] - The company has a 45% ownership interest in Sapu Biosciences, which contributed to the recent research publication [1] Research Findings - The study published in the International Journal of Molecular Sciences highlights that high TGFB2 expression correlates with reduced overall survival in patients under 65 years old, with median overall survival of 17.9 months for high TGFB2 expression compared to 66.9 months for low expression [3] - Elevated TGFB2 methylation is associated with improved survival in younger patients, with median overall survival of 66.9 months for high methylation versus 17.9 months for low methylation [3] - Clinical data from the OT-101 P001 PDAC study suggests that targeting TGFB2 is particularly beneficial for younger patients, with a median overall survival of 12.7 months in a treated subset characterized by low IL-6 [2] Market Context - The incidence of PDAC is increasing among younger adults, with approximately 4% annual growth in the 15-34 age bracket, while the five-year survival rate for all PDAC patients is only around 12% [4] - The findings underscore the need for targeted therapies like OT-101 to address the grim outcomes faced by younger PDAC patients [4]

Core Insights - Rezolve Ai is committed to executing a $1 billion Bitcoin-backed treasury strategy, which is integral to its vision for intelligent crypto payments and decentralized commerce [1][3] - The company has refined its execution plan to ensure transparency, oversight, and long-term value creation, utilizing a dedicated bankruptcy-remote special purpose vehicle (SPV) [2] - The Bitcoin Treasury strategy aims to embed Bitcoin-backed liquidity into Rezolve's AI-powered payment infrastructure, allowing real-time crypto spending for consumers while ensuring instant fiat receipt for merchants [3][4] Company Strategy - The initiative is positioned as a long-term pillar of Rezolve's platform, emphasizing the importance of precision, discipline, and structural integrity in execution [3] - The company is focused on best-in-class governance and jurisdictional scrutiny, ensuring that the long-term interests of the company, customers, and shareholders are prioritized [4] - Further progress on the Bitcoin Treasury initiative is expected to be announced in the coming months, indicating ongoing commitment and strategic priority [4] Company Overview - Rezolve Ai specializes in AI-powered solutions aimed at enhancing customer engagement, operational efficiency, and revenue growth [5] - The company's Brain Suite provides advanced tools that leverage artificial intelligence to optimize processes and improve decision-making [5]

Core Viewpoint - Genius Group Limited is providing shareholders with options to direct register their shares to mitigate the risk of their shares being lent out for short selling without their consent [2][3][4]. Group 1: Shareholder Options - Shareholders can request their brokers to transfer shares to the Direct Registration System (DRS) managed by Vstock, ensuring shares are held in the shareholder's name and cannot be lent out without consent [4][5]. - As of July 17, 2025, approximately 14.8 million shares, or 18.2% of the company's issued shares, are held at Vstock, while 81.8% remain in broker accounts [5]. Group 2: Market Manipulation Concerns - Kevin Malone, the Board Advisor, highlights that brokers are not obligated to inform shareholders when their shares are lent out, which can lead to market manipulation [2][3][6]. - Malone compares the situation to real estate transactions where a broker may act without the owner's knowledge, emphasizing the importance of control over owned assets [6]. Group 3: Company Overview - Genius Group is an AI-powered, Bitcoin-first education group serving 5.8 million users across over 100 countries, offering AI training and solutions [7]. - The company focuses on personalized, entrepreneurial AI pathways that integrate human talent with AI skills at various levels, including individual, enterprise, and government [7].